Get startedLog in
    Picture of Quantum Genomics SA logo

    ALQGC — Quantum Genomics SA News Story

    0.000.00%
    fr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: Quantum Genomics announces positive results of phase IIa study on QGC001

    Picture of Quantum Genomics SA logoQuantum Genomics SA
    19/06/2017 06:22
    June 19 (Reuters) - QUANTUM GENOMICS SA  ALQGC.PA : 
    * ANNOUNCES POSITIVE RESULTS OF ITS PHASE IIA STUDY ON 
QGC001 FOR TREATMENT OF HYPERTENSION 
    * LAUNCHES PHASE II CLINICAL STUDY IN THE US 
    * THESE DATA PAVE THE WAY FOR BRAIN AMINOPEPTIDASE A 
INHIBITORS FOR TREATMENT OF CARDIOVASCULAR DISEASES 
 
Source text: http://bit.ly/2sFWSiD 
Further company coverage:  ALQGC.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))

    Recent news on Quantum Genomics SA

    See all news